[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comments and Opinions
October 2007

Sodium Thiosulfate as First-Line Treatment for Calciphylaxis—Reply

Arch Dermatol. 2007;143(10):1331-1344. doi:10.1001/archderm.143.10.1338-a

In reply

We thank Ackermann et al for their comments regarding our case report of a patient with calciphylaxis and secondary hyperparathyroidism treated with cinacalcet.1 Cinacalcet treatment is indicated for dialysis patients with secondary hyperparathyroidism whose parathyroid hormone level is greater than 300 pg/mL. Our patient developed severe secondary hyperparathyroidism associated with parathyroid hormone levels as high as 1080 pg/mL (reference range, 7-53 pg/mL) and with varying calcium and phosphorous levels. Although not receiving dialysis, he was considered a good candidate for cinacalcet therapy with close monitoring of his parathyroid hormone, calcium, and phosphorous levels. Throughout therapy, his lowest measured parathyroid hormone level was 147 pg/mL, near the National Kidney Foundation–Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI)2 recommended range for patients with stage 5 chronic kidney disease (150-300 pg/mL).

First Page Preview View Large
First page PDF preview
First page PDF preview